Analysis portfolio

Comprehensive analysis portfolio

Analysis portfolio

More than 40,000 medicinal products are approved in Germany, taking into account the different dosage forms and strengths. For every approved medicinal product, individual analysis procedures are authorised. As an OMCL, InphA must be able to test all these medicinal products. Therefore, InphA has a very comprehensive portfolio of the most diverse analytical techniques. Furthermore, InphA can also trace and identify unexpected ingredients in medicinal products.

In our laboratories, we perform the following analytical procedures, among others:

  • Mass spectrometry (Ion Trap MSn, QTOF-HRMS)
  • High performance liquid chromatography with diverse detection possibilities (diode-array, UV/VIS, refractive index, fluorescence and electrochemical detection, universally applicable aerosol detection [light scattering, NQAD], nitrogen sensitive chemiluminescence detection, mass spectrometric detection)
  • Gas chromatography with different sample and detection possibilities (SSI, HS, FID, MS)
  • Microbiological tests according to the guidelines of the European Pharmacopoeia
  • Dissolution using different devices (online UV and online HPLC coupling, each with paddles and baskets, special accessories, such as stationary baskets over paddle for felodipine tablets and release discs and rotating cylinder for transdermal patches).
  • UV-VIS spectrometry
  • Thin layer chromatography
  • Atomic absorption and atomic emission spectrometry
  • FT infra red spectrometry with single reflex diamond ATR and ZnSe ATR crystal
  • Capillary electrophoresis
  • Gel electrophoresis
  • Immunoblotting
  • ELISA
  • Coulometry
  • Titrimetric procedures
  • Osmometry
  • Kjeldahl nitrogen assay
  • Galenical tests (e.g. disintegration of tablets, capsules and suppositories, friability, resistance to crushing)